Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial.
Liver surgery is known to be associated with significant blood loss and high requirement of blood products support, and rFVIIa has been shown in a few case reports to reduce blood loss following hepatic surgery. In this randomized placebo-controlled clinical trial, 200 patients who underwent partial hepatectomy were randomized to receive placebo, 20 g/kg or […]
